(2023). Cannabis-based magistral formulation is highly effective as an adjuvant treatment in drug-resistant focal epilepsy in adult patients: An open-label prospective cohort study.
Chicago Style (17th ed.) CitationCannabis-based Magistral Formulation Is Highly Effective as an Adjuvant Treatment in Drug-resistant Focal Epilepsy in Adult Patients: An Open-label Prospective Cohort Study. 2023.
MLA (8th ed.) CitationCannabis-based Magistral Formulation Is Highly Effective as an Adjuvant Treatment in Drug-resistant Focal Epilepsy in Adult Patients: An Open-label Prospective Cohort Study. 2023.
Warning: These citations may not always be 100% accurate.